Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 670 of 1,261
  1. US 9468649

    Methods of treating epilepsy with transforming growth factor beta inhibitors

    The Regents of the University of California · Granted Oct 18, 2016 · Expires Oct 13, 2036

    granted
  2. US 9468632

    Methods and compositions for targeting cancer stem cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 18, 2016 · Expires Oct 13, 2036

    granted
  3. US 9464035

    Salicylic acid derivatives useful as glucocerebrosidase activators

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted
  4. US 9464132

    Nanoantibodies, binding Chlamydia trachomatis antigen, method for inhibition of infection induced by Chlamydia trachomatis

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTYU “WELDUP” · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted
  5. US 9464060

    Compounds

    Takeda Pharmaceutical Company Limited · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted
  6. US 9463195

    Dissolution of amyloid fibrils by flavonoids and other compounds

    The Regents of the University of California · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted
  7. US 9464135

    Epithelial membrane protein-2 (EMP2) and proliferative vitroretinopathy (PVR)

    THE UNITED STATES OF AMERICA DEPARTMENT OF VETERAN AFFAIRS · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted
  8. US 9463166

    Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride

    RECRO GAINESVILLE LLC · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted
  9. US 9463177

    Compounds and methods for modulating vascular injury

    The Regents of the University of California · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted
  10. US 9462794

    Non-human animals having a humanized signal-regulatory protein gene

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted
  11. US 9463179

    Short acting phenylalkylamine calcium channel blockers and uses thereof

    Milestone Pharmaceuticals Inc. · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted
  12. US 9464125

    Engineered potent cytotoxic stapled BH3 peptides

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted
  13. US 9464130

    Nucleic acids encoding a cold- and menthol-sensitive receptor

    The Regents of the University of California · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted
  14. US 9464102

    Prodrugs of pyridone amides useful as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted
  15. US 9463247

    Branched alkyl and cycloalkyl terminated biodegradable lipids for the delivery of active agents

    Alnylam Pharmaceuticals, Inc. · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted
  16. US 9463254

    Molecular design toward dual-modality probes for radioisotope-based imaging (PET or SPECT) and MRI

    The Board of Regents of the University of Texas System · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted
  17. US 9463234

    Attenuated african swine fever virus strain induces protection against challenge with homologous virulent parental virus georgia 2007 isolate

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted
  18. US 9463216

    Poly-glutamic acid anti-anthrax compositions and methods for using the same

    The Regents of the University of California · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted
  19. US 9463233

    Avirulent, immunogenic flavivirus chimeras

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted
  20. US 9463220

    Method for inducing twin calving

    China Agricultural University · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted
  21. US 9463232

    Vault compositions for immunization

    The Regents of the University of California · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted
  22. US 9463193

    Individual 5-fluorouracile dose optimization in folfiri treatment

    INSTITUT DE CANCEROLOGIE DE L'OUEST · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted
  23. US 9463186

    Treatment for dopaminergic disorders

    Northwestern University · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted
  24. US 9457067

    Sialylated glycoprotein compositions and uses thereof

    Ultragenyx Pharmaceutical Inc. · Granted Oct 4, 2016 · Expires Sep 29, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.